Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products to lower middle- and middle-income families in the United States. It operates in three segments: Life Insurance, Supplemental Health Insurance, and Investments. The company offers whole, term, and other life insurance products, as well as life insurance for children; Medicare supplement and limited-benefit supplemental health insurance products, such as accident, cancer, critical illness, heart, intensive care, and other health products; and final expense, accidental death, mortgage protection, and hospital insurance products. It sells its products through direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
Resilient Growth | Globe Life demonstrates robust financial health with a 6.72% revenue growth and strong EPS performance, outpacing analyst expectations in a competitive insurance landscape |
Strategic Expansion | Explore Globe Life's agent force growth strategy, driving organic expansion and solidifying its market position in life and health insurance segments |
Margin Dynamics | Delve into Globe Life's contrasting margin performance: strong life insurance margins offset by challenges in the health insurance segment, with expectations for future improvement |
Capital Initiatives | Analysts project an average price target of $119, while Globe Life plans to unlock $1.3 billion in capital by 2025, potentially boosting shareholder returns and operational efficiency |
Metrics to compare | GL | Sector Sector - Average of metrics from a broad group of related Financial sector companies | Relationship RelationshipGLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 9.8x | 14.2x | 10.1x | |
PEG Ratio | 0.55 | −0.19 | 0.03 | |
Price/Book | 1.9x | 2.3x | 1.0x | |
Price / LTM Sales | 1.9x | 1.8x | 2.9x | |
Upside (Analyst Target) | 19.4% | 27.8% | 15.2% | |
Fair Value Upside | Unlock | 14.5% | 2.0% | Unlock |